Sort
51,593 grants matching “hepatitis”
Role of Xanthine Oxidase in Heme-induced Vascular Dysfunction
$544,905Adam Carl Straub · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL
The H3Africa Kidney Disease Cohort Study
$544,880Akinlolu O Ojo · University Of Arizona · U01 · FY2018 · DK
TTC39B in obesity and atherosclerosis
$544,861Alan Richard Tall · Columbia University Health Sciences · P01 · FY2022 · HL
TTC39B in obesity and atherosclerosis
$544,861Alan Richard Tall · Columbia University Health Sciences · P01 · FY2020 · HL
TTC39B in obesity and atherosclerosis
$544,861Alan Richard Tall · Columbia University Health Sciences · P01 · FY2019 · HL
TTC39B in obesity and atherosclerosis
$544,861Alan Richard Tall · Columbia University Health Sciences · P01 · FY2021 · HL
TTC39B in obesity and atherosclerosis
$544,861Alan Richard Tall · Columbia University Health Sciences · P01 · FY2018 · HL
Synthetic Cannabinoid Toxicity: Role of Biotransformation
$544,846Paul L Prather · Univ Of Arkansas For Med Scis · R01 · FY2019 · DA
STRUCTURE AND FUNCTION OF HUMAN TRANSLATION COMPLEXES
$544,769Jennifer A Doudna · University Of California Berkeley · P01 · FY2010 · GM
Quantitative Studies of Metabolic Organ Dynamics
$544,733Richard N. Bergman · University Of Southern California · R37 · FY2007 · DK
Hepatitis C Virus Immunobiology and Pathogenesis
$544,625Scripps Research Institute · R01 · FY2005 · CA
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
$544,567Shruti H Mehta · Johns Hopkins University · R01 · FY2014 · DA
Hepatic Wnt/LRP6 Regulation of Plasma Lipids
$544,492Arya Mani · Yale University · R01 · FY2015 · HL
REGULATION OF HEPATIC AND PERIPHERAL GLUCOSE METABOLISM
$544,474University Of Texas Hlth Sci Ctr San Ant · R01 · FY2001 · DK
ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE
$544,399Heather L Stevenson · University Of Texas Med Br Galveston · R01 · FY2021 · DK
Mechanisms Linking Nonmedical Prescription Drug Use and Injection Drug Use
$544,393Scott Novak · Research Triangle Institute · R01 · FY2012 · DA
The Environment as a Variable to Calibrate Mouse Models of Human Disease
$544,391John M Essigmann · Massachusetts Institute Of Technology · R01 · FY2008 · ES
Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infection
$544,369Tuoqi Wu · Ut Southwestern Medical Center · R01 · FY2024 · AI
Mechanisms of antibody-mediated control of repeated hepatitis C virus infection in humans
$544,334Justin Richard Bailey · Johns Hopkins University · U19 · FY2022 · AI
Innovative Genetic Approaches to Enhance Liver Repopulation and Reduce Cancer Risk and Progression
$544,332Klaus H. Kaestner · University Of Pennsylvania · R01 · FY2021 · CA
Innovative Genetic Approaches to Enhance Liver Repopulation and Reduce Cancer Risk and Progression
$544,332Klaus H. Kaestner · University Of Pennsylvania · R01 · FY2020 · CA
Prenatal Anxiety and its Effects on Child Development
$544,322Thomas G O'Connor · University Of Rochester · R01 · FY2011 · MH
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling
$544,109Susan L Uprichard · Loyola University Chicago · R01 · FY2016 · AI
Brief Intervention for Drug Misuse for the Emergency Department (BIDMED)
$544,040Roland C Merchant · Rhode Island Hospital · R01 · FY2013 · DA
In Vitro Antiviral Screening Program
$544,000Michael Murry · Southern Research Institute · N01 · FY2011 · AI